Allan J. Schutt

6.0k total citations · 2 hit papers
86 papers, 3.8k citations indexed

About

Allan J. Schutt is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Allan J. Schutt has authored 86 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Oncology, 25 papers in Pulmonary and Respiratory Medicine and 23 papers in Molecular Biology. Recurrent topics in Allan J. Schutt's work include Colorectal Cancer Treatments and Studies (24 papers), Gastric Cancer Management and Outcomes (13 papers) and Cancer therapeutics and mechanisms (11 papers). Allan J. Schutt is often cited by papers focused on Colorectal Cancer Treatments and Studies (24 papers), Gastric Cancer Management and Outcomes (13 papers) and Cancer therapeutics and mechanisms (11 papers). Allan J. Schutt collaborates with scholars based in United States, South Africa and Italy. Allan J. Schutt's co-authors include Charles G. Moertel, C G Moertel, Michael J. O’Connell, Richard J. Reitemeier, R. G. Hahn, Richard G. Hahn, Joseph Rubin, Larry K. Kvols, Judith R. OʼFallon and Edward T. Creagan and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.

In The Last Decade

Allan J. Schutt

85 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treatment of the Malignant Carcinoid Syndrome

1986 656 citations Larry K. Kvols, Charles G. Moertel et al. profile →
Failure of High-Dose Vitamin C (Ascorbic Acid) Therapy to Benefit Patients with Advanced Cancer

1979 416 citations Edward T. Creagan, Charles G. Moertel et al. profile →

Peers

Allan J. Schutt

ONCOL

EPIDE

SURGE

PRM

Harold O. Douglass United States

C G Moertel United States

Thomas Aparicio France

John W. Kugler United States

Svein Dueland Norway

Axel Holstege Germany

Yuji Yamamoto Japan

Chun‐Nan Yeh Taiwan

Nils Homann Germany

Eugene A. Woltering United States

Harold O. Douglass United States

Allan J. Schutt

1.5k ×0.7

ONCOL

404 ×0.4

EPIDE

1.4k ×1.8

SURGE

1.3k ×1.8

PRM

518 ×0.8

Citations per year, relative to Allan J. Schutt Allan J. Schutt (= 1×) peers Harold O. Douglass

Countries citing papers authored by Allan J. Schutt

Since Specialization

Citations

This map shows the geographic impact of Allan J. Schutt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allan J. Schutt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allan J. Schutt more than expected).

Fields of papers citing papers by Allan J. Schutt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allan J. Schutt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allan J. Schutt. The network helps show where Allan J. Schutt may publish in the future.

Co-authorship network of co-authors of Allan J. Schutt

This figure shows the co-authorship network connecting the top 25 collaborators of Allan J. Schutt. A scholar is included among the top collaborators of Allan J. Schutt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allan J. Schutt. Allan J. Schutt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Witte, Robert S., et al.. (2001). Comparison of 5-fluorouracil alone, 5-fluorouracil with levamisole, and 5-fluorouracil with hepatic irradiation in the treatment of patients with residual, nonmeasurable, intra-abdominal metastasis after undergoing resection for colorectal carcinoma. Cancer. 91(5). 1020–1028. 7 indexed citations

Novik, Yelena, et al.. (1999). Phase II protocol for the evaluation of new treatments in patients with advanced gastric carcinoma: results of ECOG 5282. Medical Oncology. 16(4). 261–266. 14 indexed citations

Witte, Robert S., Louise Ryan, Allan J. Schutt, Paul P. Carbone, & Paul F. Engstrom. (1998). Pala Versus Streptozotocin, Doxorubicin, and Meccnu in the Treatment of Patients With Advanced Pancreatic Carcinoma. Investigational New Drugs. 16(4). 315–318. 1 indexed citations

Rubin, Joseph, James Gallagher, Georgene Schroeder, et al.. (1996). Phase II trials of 5-fluorouracil and leucovorin in patients with metastatic gastric or pancreatic carcinoma. Cancer. 78(9). 1888–1891. 42 indexed citations

Moertel, Charles G., H. Samuel Wieand, James E. Krook, et al.. (1995). A phase III evaluation of a somatostatin analogue (octreotide) in the treatment of patients with asymptomatic advanced colon carcinoma. Cancer. 76(6). 961–966. 32 indexed citations

Earle, John D., John Foley, Harry S. Wieand, et al.. (1994). Evaluation of external-beam radiation therapy plus 5-fluorouracil (5-FU) versus external-beam radiation therapy plus hycanthone (HYC) in confined, unresectable pancreatic cancer. International Journal of Radiation Oncology*Biology*Physics. 28(1). 207–211. 20 indexed citations

Martenson, James A., Allan J. Schutt, Gordon L. Grado, William J. Maples, & Robert F. Marschke. (1994). Prospective phase I evaluation of radiation therapy, 5-fluorouracil, and levamisole in locally advanced gastrointestinal cancer. International Journal of Radiation Oncology*Biology*Physics. 28(2). 439–443. 1 indexed citations

Kardinal, Carl G., Charles G. Moertel, H. Samuel Wieand, et al.. (1993). Combined doxorubicin and alpha-interferon therapy of advanced hepatocellular carcinoma. Cancer. 71(7). 2187–2190. 36 indexed citations

Kimmel, David W. & Allan J. Schutt. (1993). Multifocal Leukoencephalopathy: Occurrence During 5-Fluorouracil and Levamisole Therapy and Resolution After Discontinuation of Chemotherapy. Mayo Clinic Proceedings. 68(4). 363–365. 31 indexed citations

10.

Pitot, Henry C., Joseph Rubin, J. S. Kovach, Allan J. Schutt, & Peter C. Adamson. (1993). all‐trans Retinoic Acid: a Dose‐Seeking Study in Solid Tumors. Annals of the New York Academy of Sciences. 691(1). 250–252. 2 indexed citations

11.

Rubin, Joseph, Allan J. Schutt, & Henry C. Pitot. (1992). A Phase II Study of Intravenous 6-Thioguanine (NSC-752) in Advanced Colorectal Carcinoma. American Journal of Clinical Oncology. 15(3). 236–238. 2 indexed citations

12.

Cullinan, Stephen A., Charles G. Moertel, Harry S. Wieand, et al.. (1990). A phase III trial on the therapy of advanced pancreatic carcinoma evaluations of the mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin. Cancer. 65(10). 2207–2212. 171 indexed citations

13.

O’Connell, Michael J., et al.. (1989). Recombinant interferon-γ lacks activity against metastatic colorectal cancer but increases serum levels of ca 19-9. Cancer. 63(10). 1998–2004. 18 indexed citations

14.

Creagan, Edward T., J. N. Ingle, Allan J. Schutt, & Daniel J. Schaid. (1989). A Prospective, Randomized Controlled Trial of Megestrol Acetate Among High-Risk Patients with Resected Malignant Melanoma. American Journal of Clinical Oncology. 12(2). 152–155. 25 indexed citations

15.

Long, Harry J., Daniel J. Schaid, Allan J. Schutt, et al.. (1988). Phase II Evaluation of Menogaril in Women with Metastatic Breast Cancer after Failure of First-Line Chemotherapy. American Journal of Clinical Oncology. 11(5). 524–527. 7 indexed citations

16.

Ryan, Louise, Lewis A. Johnson, I. W. Simson, et al.. (1987). A random phase II study of mitoxantrone and cisplatin in patients with hepatocellular carcinoma: An ECOG study. Cancer. 60(9). 2141–2145. 67 indexed citations

17.

Moertel, C G, Donald S. Childs, Judith R. OʼFallon, et al.. (1984). Combined 5-fluorouracil and radiation therapy as a surgical adjuvant for poor prognosis gastric carcinoma.. Journal of Clinical Oncology. 2(11). 1249–1254. 152 indexed citations

18.

Moertel, Charles G., Roy E. Ritts, Allan J. Schutt, & Richard G. Hahn. (1975). Clinical studies of methanol extraction residue fraction of Bacillus Calmette-Guérin as an immunostimulant in patients with advanced cancer.. PubMed. 35(11 Pt 1). 3075–83. 48 indexed citations

19.

Schutt, Allan J., et al.. (1973). Diagnosis of Meckel’s Diverticulum by Radioisotope Scanning. Mayo Clinic Proceedings. 48(2). 98–102. 1 indexed citations

20.

Moertel, C G, Allan J. Schutt, Richard J. Reitemeier, & R. G. Hahn. (1972). Sequential 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) and 5-fluorouracil (NSC 19893) therapy of gastrointestinal cancer.. PubMed. 32(6). 1280–2. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact